Total Payments
$2,436
2024 Payments
$1,097
Companies
23
Transactions
124
Medicare Patients
604
Medicare Billing
$52,079
Payment Breakdown by Category
Food & Beverage$2,399 (98.5%)
Education$37.02 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,399 | 121 | 98.5% |
| Education | $37.02 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $543.40 | 26 | $0 (2024) |
| GENZYME CORPORATION | $408.77 | 16 | $0 (2024) |
| Amgen Inc. | $254.27 | 15 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $226.66 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $190.92 | 10 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $107.03 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $91.94 | 4 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $86.58 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $84.47 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $84.37 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,097 | 47 | GENZYME CORPORATION ($408.77) |
| 2023 | $473.92 | 25 | AstraZeneca Pharmaceuticals LP ($154.71) |
| 2022 | $420.92 | 26 | E.R. Squibb & Sons, L.L.C. ($196.86) |
| 2021 | $444.63 | 26 | Amgen Inc. ($197.88) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Immunology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Immunology | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $29.19 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Immunology | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.64 | General |
| 09/04/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Immunology | ||||||
| 07/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 85 | 123 | $16,444 | $7,405 |
| 2022 | 3 | 222 | 261 | $40,480 | $19,858 |
| 2021 | 2 | 145 | 174 | $27,620 | $14,434 |
| 2020 | 3 | 152 | 166 | $24,540 | $10,383 |
Total Patients
604
Total Services
724
Medicare Billing
$52,079
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 72 | $7,284 | $3,733 | 51.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $5,730 | $2,557 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 21 | $3,430 | $1,115 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 207 | $31,050 | $15,721 | 50.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $7,130 | $2,914 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $2,300 | $1,223 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 126 | 155 | $23,250 | $12,414 | 53.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $4,370 | $2,019 | 46.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 73 | $10,950 | $4,237 | 38.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $7,590 | $3,287 | 43.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 60 | $6,000 | $2,859 | 47.6% |
About Amanda Mcmasters, NP
Amanda Mcmasters, NP is a Registered Nurse healthcare provider based in Duncan, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2017. The National Provider Identifier (NPI) number assigned to this provider is 1467970657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Mcmasters, NP has received a total of $2,436 in payments from pharmaceutical and medical device companies, with $1,097 received in 2024. These payments were reported across 124 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,399).
As a Medicare-enrolled provider, Mcmasters has provided services to 604 Medicare beneficiaries, totaling 724 services with total Medicare billing of $52,079. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Duncan, OK
- Active Since 09/07/2017
- Last Updated 03/20/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1467970657
Products in Payments
- DUPIXENT (Biological) $515.56
- FASENRA (Biological) $264.94
- Repatha (Biological) $254.27
- TEZSPIRE (Biological) $139.32
- CAMZYOS (Drug) $136.14
- ELIQUIS (Drug) $122.05
- LEQVIO (Drug) $116.09
- LifeVest (Device) $107.03
- XARELTO (Drug) $91.94
- GLASSIA (Biological) $86.58
- ENTRESTO (Drug) $74.83
- VERQUVO (Drug) $65.66
- BRILINTA (Drug) $61.29
- FARXIGA (Drug) $55.35
- TRELEGY ELLIPTA (Drug) $50.95
- Rybelsus (Drug) $32.21
- Assure WCD (Device) $29.19
- OPSUMIT (Drug) $27.17
- TYVASO (Drug) $25.46
- Hillrom - Carnation Ambulatory Monitor (Device) $23.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.